Defining End Points in Phase II Trials of Metastatic Castration-Resistant Prostate Cancer. Re: Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study.
作者信息
O'Reilly David
机构信息
Department of Medical Oncology, Mater Misericordiae University Hospital, Dublin, Ireland.
出版信息
Clin Genitourin Cancer. 2019 Oct;17(5):e886-e887. doi: 10.1016/j.clgc.2019.07.010. Epub 2019 Jul 19.
PMID:31409550
Abstract
摘要
Zotero 插件